维普中文期刊产品整合服务
133篇 您的检索式:作者名="Wu PL"
    题名 作者 年代 出处 被引量
1Comparing diffusion-weighted and T2-weighted MR imaging for the quantification of infarct size in a neonatal rat hypoxic-ischemic model at 24 h post-injury显示文摘Wang, YX Cheung, PT Shen, GX Bhatia, I Wu, EX Qiu, DQ Khong, PL 2007中国生物学文摘2007,21,11:2
2Cilostazol for secondary stroke prevention:systematic review and meta-analysis显示文摘Background Stroke is one of the leading causes of death worldwide.Cilostazol,an antiplatelet and phosphodiesterase 3 inhibitor,has not been clearly established for ischaemic stroke use.We aim to determine the efficacy and safety of cilostazol for secondary stroke prevention.Methods MEDLINE,EMBASE,Cochrane Library,Web of Science and ClinicalTrials.gov were searched from inception to 25 September 2020,for randomised trials comparing the efficacy and safety of cilostazol monotherapy or dual therapy with another antiplatelet regimen or placebo,in patients with ischaemic stroke.Version 2 of the Cochrane risk-of-bias tool for randomised trials(RoB 2)was used to assess study quality.This meta-analysis was reported in line with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses(PRISMA)statement.Results Eighteen randomised trials comprising 11429 participants were included in this meta-analysis.Most trials possessed low risk of bias and were of low heterogeneity.Cilostazol significantly reduced the rate of ischaemic stroke recurrence(risk ratio,RR=0.69,95%CI 0.58 to 0.81),any stroke recurrence(RR=0.64,95%CI 0.54 to 0.74)and major adverse cardiovascular events(RR=0.67,95%CI 0.56 to 0.81).Cilostazol did not significantly decrease mortality(RR=0.90,95%CI 0.64 to 1.25)or increase the rate of good functional outcome(Modified Rankin Scale score of 0–1;RR=1.07,95%CI 0.95 to 1.19).Cilostazol demonstrated favourable safety profile,significantly reducing the risk of intracranial haemorrhage(RR=0.46,95%CI 0.31 to 0.68)and major haemorrhagic events(RR=0.49,95%CI 0.34 to 0.70).Conclusions Cilostazol demonstrated superior efficacy and safety profiles compared with traditional antiplatelet regimens such as aspirin and clopidogrel for secondary stroke prevention but does not appear to affect functional outcomes.Future randomised trials can be conducted outside East Asia,or compare cilostazol with a wider range of antiplatelet agents.Choon Han Tan Andrew GR Wu Ching-Hui Sia Aloysius ST Leow Bernard PL Chan Vijay Kumar Sharma Leonard LL Yeo Benjamin YQ Tan 2021Stroke & Vascular Neurology2021,6,3:2
3A crossover study on lipid and weight changes associated with olanzapine and risperi- done显示文摘Su KP Wu PL Pariante CM 2005Psychopharmacology2005,183,3:1
4Inverse temporal changes of lipoxin A4 and leuko/rienes in children with Henoch-SchOnlein purpura 显示文摘Wu SH Liao PY Yin PL 2009Prostaglandins Leukot Essent Fatty Acids2009,80,4:1
5The relationship among turnover intentions, professional commitment, and job satisfaction of hospital nurse显示文摘KY Lin PL Wu CM 2002Journal of Professional Nursing2002,18,4:1
6Patellar reshaping versus resurfacing in total knee arthroplasty-Results of a randomized prospective trial at a minimum of 7 years'follow-up显示文摘Liu ZT Fu PL Wu HS 2012Knee2012,19,3:1
7Role of glycosphingolipid conformtional change in membrane pore forming activity of cobra cardiotoxin显示文摘Tjong SC Wu PL Wang CM 2007Biochemistry2007,46,12:1
8Quadruple rescue therapy for Helicobacter pylori infection after two treatment failures显示文摘Hsu Pl Wu I)(2 Chen A etal Eur J Clin Invest 20(8 38(6) :404 4090,,:1
9Inverse tempo- ral chan- ges of lipoxin A4 and leukotrienes in children with Henoch - Sch-inlein purpura 显示文摘Wu SH Liao PY Yin PL 2009Prostaglandins Leukot Essent Fatty Acids2009,80,4:1
10Omentin - 1 attenuates arteriral calci- fication and boner loss in osteoprotegerin-deficient mice by inhibition of RANKL expression显示文摘Xie H Xie PL Wu XP 2011Cardiovasc Res2011,92,2:1
11MicroRNA-21 pro- motes tumour malignancy via increased nuclear transloea- tion of ]3-catenin and predicts poor outcome in APC-muta- ted but not in APC-wild-type colorectal cancer 显示文摘Lin PL Wu DW Huang CC 2014Carci- nogenesis2014,35,:1
12Carbazole alkaloids from Clausena excavata and their biological activity 显示文摘Wu TS Huang SC Wu PL 1996Phyto- chemistry1996,43,1:1
13The outcome of patients on dialysis with upper urinary tract transitional cell carcinoma显示文摘WU CF CHANG PL CHEN CS 2006J Urol2006,176,2:1
14Shopping experiences : International tourists in Beijing's Silk Market显示文摘Wu M - Y Wall G Pearce PL 2014Tourism Management2014,41,:1
15Complete sequencing of pNDM-HK encoding NDM-1 carbapenemase from a multidrug- resistant Escherichia coli strain isolated in Hang Kong 显示文摘Ho PL Lo WU Yeung MK et ol 2011PLoS One2011,6,17:1
16Robust and efficient synthetic method for forming DNA microarrays 显示文摘Dolan PL WU Yang Ista LK 2001Nucleic Acids Research2001,29,21:1
17Inverse temporal changes of lipoxin A4 and leukotrienes in children with Henoch- Sch0nlein purpura显示文摘Wu SH Liao PY Yin PL 2009Prostaglandins Leukot Essent Fatty Acids2009,80,4:1
18Extraintestinal focal infections in adults with Salmonella enteriea serotype Choleraesuis baeteremia显示文摘Chen PL Wu CJ Chang CM 2007J Microbiollmmunol Infect2007,40,3:1
19Two coumarins from the root bark of Clausena excavate 显示文摘Huang SC Wu PL Wu TS 1997Phytochemistry1997,44,1:1
20Neuroleptic malignant syn-drome after the use of venlafaxine in a patient with generalizedanxiety disorder 显示文摘Lu TC Chu PL Wu CS 2006J Formos Med Assoc2006,105,1:1
返回顶部 每页显示:
共7页 首页 上一页 第1页 下一页 末页 /7 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费